US Blood Transfusion Diagnostics Market Size, Share, Growth, Analysis Report 2023
The US blood transfusion diagnostics market size was valued at USD 1.91 billion in 2021. The market is projected to grow from USD 2.20 billion in 2022 to USD 3.58 billion by 2029, exhibiting a CAGR of 7.2% during the forecast period. This information is presented by Fortune Business Insights, in its report titled, “US Blood Transfusion Diagnostics Market, 2022-2029.” Key Industry Development: June 2022 : Alba Bioscience Limited (QUOTIENT LIMITED) made an announcement that they have been granted the US FDA sanction for ORTHO Sera and ALBAclone blood grouping reagents. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-blood-transfusion-diagnostics-market-107024 Drivers and Restraints: Rising Demand for Blood and Blood Components to Accelerate the US Blood Transfusion Diagnostics Market Growth The rising incidence of blood-related diseases such as hemophilia, leukemia, and ...